Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Histone deacetylases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression. HDACs are involved in cell-cycle progression and differentiation, and their deregulation is associated with several cancers. HDAC inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), have anti-tumour effects, as they can inhibit cell growth, induce terminal differentiation and prevent the formation of tumours in mice models, and they are effective in the treatment of promyelocytic leukemia. Here we describe the structure of the histone deacetylase catalytic core, as revealed by the crystal structure of a homologue from the hyperthermophilic bacterium Aquifex aeolicus, that shares 35.2% identity with human HDAC1 over 375 residues, deacetylates histones in vitro and is inhibited by TSA and SAHA. The deacetylase, deacetylase-TSA and deacetylase-SAHA structures reveal an active site consisting of a tubular pocket, a zinc-binding site and two Asp-His charge-relay systems, and establish the mechanism of HDAC inhibition. The residues that make up the active site and contact the inhibitors are conserved across the HDAC family. These structures also suggest a mechanism for the deacetylation reaction and provide a framework for the further development of HDAC inhibitors as antitumour agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conformation of this loop is virtually identical in the three HDLP structures (Finnin et al., 1999), suggesting that the surface of HDLP is less malleable than that of HDAC8 around the binding site pocket.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“The apparent reduced flexibility in the HDLP surface may also explain why it is less efficient in histone deacetylase assays (Finnin et al., 1999).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“Finnin et al. (1999) have suggested that H143 protonates the lysine after the carbon-nitrogen scissile bond breaks.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Finnin et al., 1999
In the citing paper
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Finnin et al., 1999
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
[26] Raster3D: Photorealistic molecular graphics
Merritt, E. A., & Bacon, D. J. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77028-9 · Cited by 3,739
The relation between the divergence of sequence and structure in proteins.
Chothia, C., & Lesk, A. M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04288.x · Cited by 2,458
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
The complete genome of the hyperthermophilic bacterium Aquifex aeolicus
Deckert, G., Warren, P. V., Gaasterland, T., Young, W. G., Lenox, A. L., Graham, D. E., Overbeek, R., Snead, M. A., Keller, M., Aujay, M., et al. (1998) · Nature · doi:10.1038/32831 · Cited by 1,097
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
Self-citation
Research works printed but not linked: 2
- Cohen,L. A. et al. Inhibition of N-methylnitrosourea-induced tumours by the cytodifferentiating agent, suberanilohydroxamic acid (SAHA). Proc. AACR 39, 108, abstr. 736 (1998).
- Desai,D., El-Bayoumy,K. & Amin,S. Chemopreventive efficacy of suberanilohydroxamic acid (SAHA), a cytodifferentiating agent, against tobacco-specific nitrosamine 4-(methylinitros-amino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice. Proc. AACR 40, 2396, abstr. 362 (1999).
Cited by
Items 201–300 of 1,007
Transcription therapy for cancer
Pandolfi, P. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204299 · Cited by 179
Bora-Tatar, G., Dayangaç-Erden, D., Demir, A. S., Dalkara, S., Yelekçi, K., & Erdem-Yurter, H. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.042 · Cited by 178
Mishra, N., Brown, D. R., Olorenshaw, I. M., & Kammer, G. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051507098 · Cited by 178
Marek, L., Hamacher, A., Hansen, F. K., Kuna, K., Gohlke, H., Kassack, M. U., & Kurz, T. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301254q · Cited by 177
Zinc hydrolases: the mechanisms of zinc-dependent deacetylases
Hernick, M., & Fierke, C. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.08.006 · Cited by 177
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
Hontecillas-Prieto, L., Flores-Campos, R., Silver, A., de Álava, E., Hajji, N., & García-Domínguez, D. J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.578011 · Cited by 177
Mimasu, S., Umezawa, N., Sato, S., Higuchi, T., Umehara, T., & Yokoyama, S. (2010) · Biochemistry · doi:10.1021/bi100299r · Cited by 175
Requirement for RAR-mediated gene repression in skeletal progenitor differentiation
Weston, A. D., Chandraratna, R. A. S., Torchia, J., & Underhill, T. M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200112029 · Cited by 174
Wu, H.-M., Tzeng, N.-S., Qian, L., Wei, S.-J., Hu, X., Chen, S.-H., Rawls, S. M., Flood, P., Hong, J.-S., & Lu, R.-B. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.64 · Cited by 174
Marek, M., Kannan, S., Hauser, A.-T., Moraes Mourão, M., Caby, S., Cura, V., Stolfa, D. A., Schmidtkunz, K., Lancelot, J., Andrade, L., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003645 · Cited by 173
Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders
Pang, M., & Zhuang, S. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168385 · Cited by 173
Crystal Structure of a Bacterial Class 2 Histone Deacetylase Homologue
Nielsen, T. K., Hildmann, C., Dickmanns, A., Schwienhorst, A., & Ficner, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.065 · Cited by 173
Epigenomics and epigenetic therapy of cancer
Brown, R., & Strathdee, G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02314-6 · Cited by 172
Zinc metalloproteins as medicinal targets
Anzellotti, A. I., & Farrell, N. P. (2008) · Chemical Society Reviews · doi:10.1039/b617121b · Cited by 172
Histone Deacetylases: A Saga of Perturbed Acetylation Homeostasis in Cancer
Parbin, S., Kar, S., Shilpi, A., Sengupta, D., Deb, M., Rath, S. K., & Patra, S. K. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413506582 · Cited by 172
Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis
Kwon, H. J., Kim, M. S., Kim, M. J., Nakajima, H., & Kim, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.1602 · Cited by 171
HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain
Denk, F., Huang, W., Sidders, B., Bithell, A., Crow, M., Grist, J., Sharma, S., Ziemek, D., Rice, A. S. C., Buckley, N. J., et al. (2013) · Pain · doi:10.1016/j.pain.2013.05.021 · Cited by 171
Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines
Sakajiri, S., Kumagai, T., Kawamata, N., Saitoh, T., Said, J. W., & Koeffler, H. P. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.09.008 · Cited by 169
Histone-Deacetylase Inhibitors for the Treatment of Cancer
Lindemann, R. K., Gabrielli, B. G., & Johnstone, R. W. (2004) · Cell Cycle · doi:10.4161/cc.3.6.927 · Cited by 168
Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist
Li, X., Li, X., Liu, F., Li, S., & Shi, D. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00683 · Cited by 168
Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis
Whittington, D. A., Rusche, K. M., Shin, H., Fierke, C. A., & Christianson, D. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432990100 · Cited by 167
Epigenetics and Complex Disease: From Etiology to New Therapeutics
Ptak, C., & Petronis, A. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094731 · Cited by 167
Moradei, O. M., Mallais, T. C., Frechette, S., Paquin, I., Tessier, P. E., Leit, S. M., Fournel, M., Bonfils, C., Trachy-Bourget, M.-C., Liu, J., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701079h · Cited by 166
HDAC inhibitors and immunotherapy; a double edged sword?
Kroesen, M., Gielen, P. R., Brok, I. C., Armandari, I., Hoogerbrugge, P. M., & Adema, G. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2289 · Cited by 166
Arginase: Structure, Mechanism, and Physiological Role in Male and Female Sexual Arousal
Christianson, D. W. (2005) · Accounts of Chemical Research · doi:10.1021/ar040183k · Cited by 166
Huber, L. C., Distler, J. H. W., Moritz, F., Hemmatazad, H., Hauser, T., Michel, B. A., Gay, R. E., Matucci‐Cerinic, M., Gay, S., Distler, O., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22759 · Cited by 165
Trifluoromethyl ketones as inhibitors of histone deacetylase
Frey, R. R., Wada, C. K., Garland, R. B., Curtin, M. L., Michaelides, M. R., Li, J., Pease, L. J., Glaser, K. B., Marcotte, P. A., Bouska, J. J., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00754-0 · Cited by 165
Whitehead, L., Dobler, M. R., Radetich, B., Zhu, Y., Atadja, P. W., Claiborne, T., Grob, J. E., McRiner, A., Pancost, M. R., Patnaik, A., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.030 · Cited by 164
Suberoylanilide Hydroxamic Acid as a Potential Therapeutic Agent for Human Breast Cancer Treatment
Huang, L., & Pardee, A. B. (2000) · Molecular Medicine · doi:10.1007/bf03401823 · Cited by 164
HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases
Li, G., Jiang, H., Chang, M., Xie, H., & Hu, L. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.02.017 · Cited by 163
Komatsu, Y., Tomizaki, K., Tsukamoto, M., Kato, T., Nishino, N., Sato, S., Yamori, T., Tsuruo, T., Furumai, R., Yoshida, M., et al. (2001) · PubMed · Cited by 163
HDAC1 Acetylation Is Linked to Progressive Modulation of Steroid Receptor-Induced Gene Transcription
Qiu, Y., Zhao, Y., Becker, M., John, S., Parekh, B. S., Huang, S., Hendarwanto, A., Martinez, E. D., Chen, Y., Lu, H., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.04.019 · Cited by 162
Sato, N., Fukushima, N., Chang, R., Matsubayashi, H., & Goggins, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.008 · Cited by 162
Yin, D., Ong, J. M., Hu, J., Desmond, J. C., Kawamata, N., Konda, B. M., Black, K. L., & Koeffler, H. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1261 · Cited by 162
The Histone Deacetylase Inhibitor Trichostatin A Promotes Totipotency in the Male Gametophyte
Li, H., Soriano, M., Cordewener, J. H. G., Muiño, J. M., Riksen, T., Fukuoka, H., Angenent, G. C., & Boutilier, K. (2014) · The Plant Cell · doi:10.1105/tpc.113.116491 · Cited by 162
Histone deacetylase inhibitors open new doors in cancer therapy
McLaughlin, F., & Thangue, N. B. L. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.034 · Cited by 161
Characterization of the two catalytic domains in histone deacetylase 6
Zou, H., Wu, Y., Navre, M., & Sang, B. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.144 · Cited by 160
Li, Z., & Zhu, W.-G. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9067 · Cited by 160
Earley, K. W., Pontvianne, F., Wierzbicki, A. T., Blevins, T., Tucker, S., Costa-Nunes, P., Pontes, O., & Pikaard, C. S. (2010) · Genes & Development · doi:10.1101/gad.1914110 · Cited by 160
Epigenetic polypharmacology: from combination therapy to multitargeted drugs
de Lera, Á. R., & Ganesan, A. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0271-9 · Cited by 160
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
Szymański, W., Ourailidou, M. E., Velema, W. A., Dekker, F. J., & Feringa, B. L. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201502809 · Cited by 159
Regulation of the chondrogenic phenotype in culture
Bobick, B. E., Chen, F. H., Le, A. M., & Tuan, R. S. (2009) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20167 · Cited by 159
Thakur, V. S., Gupta, K., & Gupta, S. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr277 · Cited by 158
Genome-wide analysis of HDAC function
Ekwall, K. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.08.009 · Cited by 157
Next-generation of selective histone deacetylase inhibitors
Yang, F., Zhao, N., Ge, D., & Chen, Y. (2019) · RSC Advances · doi:10.1039/c9ra02985k · Cited by 157
Dietary Manipulation of Histone Structure and Function
Delage, B., & Dashwood, R. H. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155354 · Cited by 155
Epigenetic regulation of nervous system development by DNA methylation and histone deacetylation
MacDonald, J. L., & Roskams, A. J. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.002 · Cited by 154
Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A
Lee, H., Rezai-Zadeh, N., & Seto, E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.765-773.2004 · Cited by 153
“The crystal structure of the Aquifex aeolicus HDAC homolog, HDLP, shows that Ser29 (corresponding to Ser39 of human HDAC8) lies within the second helix, adjacent to the first loop, of HDLP (12).”
BackgroundConti, C., Leo, E., Eichler, G. S., Sordet, O., Martin, M. M., Fan, A., Aladjem, M. I., & Pommier, Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3028 · Cited by 151
Woyach, J. A., Kloos, R. T., Ringel, M. D., Arbogast, D., Collamore, M., Zwiebel, J. A., Grever, M., Villalona-Calero, M., & Shah, M. H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1631 · Cited by 151
HDAC inhibitor-based therapies and haematological malignancy
Stimson, L., Wood, V. H. J., Khan, O. A., Fotheringham, S. A., & Thangue, N. B. L. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn792 · Cited by 150
Gantt, S. L., Gattis, S. G., & Fierke, C. A. (2006) · Biochemistry · doi:10.1021/bi060212u · Cited by 150
Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases
Porter, N. J., & Christianson, D. W. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.01.004 · Cited by 146
Godschalk, R., van Schooten, F., & Bartsch, H. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.001 · Cited by 146
Histone Deacetylase in Carcinogenesis and Its Inhibitors as Anti-cancer Agents
Kim, D. H., Kim, M., & Kwon, H.-J. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.110 · Cited by 146
Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging
Krishnan, M., Park, J. M., Cao, F., Wang, D., Paulmurugan, R., Tseng, J. R., Gonzalgo, M. L., Gambhir, S. S., & Wu, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.05-4551fje · Cited by 146
Langley, B., D'Annibale, M. A., Suh, K., Ayoub, I., Tolhurst, A., Bastan, B., Yang, L., Ko, B., Fisher, M., Cho, S., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3200-07.2008 · Cited by 145
Bontempo, P., Mita, L., Miceli, M., Doto, A., Nebbioso, A., Bellis, F. D., Conte, M., Minichiello, A., Manzo, F., Carafa, V., et al. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.05.010 · Cited by 145
Expression of Endomembrane Calcium Pumps in Colon and Gastric Cancer Cells
Gélébart, P., Kovàcs, T., Brouland, J., van Gorp, R. M. A., Grossmann, J., Rivard, N., Panis, Y. H., Martin, V., Bredoux, R., Enouf, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201747200 · Cited by 145
Bates, E. A., Victor, M., Jones, A. K., Shi, Y., & Hart, A. C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3344-05.2006 · Cited by 144
Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
Verza, F. A., Das, U., Fachin, A. L., Dimmock, J. R., & Marins, M. (2020) · Cancers · doi:10.3390/cancers12061664 · Cited by 143
Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors
Guerrant, W., Patil, V., Canzoneri, J. C., & Oyelere, A. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm200799p · Cited by 143
Structure and activity of enzymes that remove histone modifications
Holbert, M. A., & Marmorstein, R. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.10.006 · Cited by 143
Zhang, X.-H., Qin-Ma, Wu, H.-P., Khamis, M. Y., Li, Y.-H., Ma, L.-Y., & Liu, H.-M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01782 · Cited by 143
Hydroxyurea and hydroxamic acid derivatives as antitumor drugs
Šaban, N., & Bujak, M. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-0991-z · Cited by 143
Histone Deacetylase Inhibitors in Programmed Cell Death and Cancer Therapy
Marks, P. A., & Jiang, X. (2005) · Cell Cycle · doi:10.4161/cc.4.4.1564 · Cited by 142
Self-citationZHAO, T., CHENG, G., ZHANG, L., TSENG, Y., & PADBURY, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.08.010 · Cited by 141
Butler, L. M., Webb, Y., Agus, D. B., Higgins, B., Tolentino, T., Kutko, M. C., LaQuaglia, M. P., Drobnjak, M., Cordon‐Cardo, C., Scher, H. I., et al. (2001) · PubMed · Cited by 141
Self-citationSternson, S. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2001) · Organic Letters · doi:10.1021/ol016915f · Cited by 141
Wang, D.-F., Wiest, O., Helquist, P., Lan-Hargest, H.-Y., & Wiech, N. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0498497 · Cited by 141
Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy
Spiegel, S., Milstien, S., & Grant, S. (2012) · Oncogene · doi:10.1038/onc.2011.267 · Cited by 141
Inhibitors of histone deacetylase are potentially effective anticancer agents.
Marks, P. A., Rifkind, R. A., Richon, V. M., & Breslow, R. (2001) · PubMed · Cited by 140
Self-citationIdentification of a nuclear domain with deacetylase activity
Downes, M., Ordentlich, P., Kao, H.-Y., Alvarez, J. G. A., & Evans, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10330 · Cited by 139
Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells
Larsen, L. H., Tonnesen, M., Rønn, S. G., Størling, J., Jørgensen, S. W., Mascagni, P., Dinarello, C. A., Billestrup, N., & Mandrup-Poulsen, T. R. (2007) · Diabetologia · doi:10.1007/s00125-006-0562-3 · Cited by 138
A phase 2 study of vorinostat in acute myeloid leukemia
Schaefer, É., Loaiza‐Bonilla, A., Juckett, M. B., DiPersio, J. F., Roy, V., Slack, J. L., Wu, W., Laumann, K. M., Espinoza‐Delgado, I., & Gore, S. D. (2009) · Haematologica · doi:10.3324/haematol.2009.009217 · Cited by 138
β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: An update
Tranoy‐Opalinski, I., Legigan, T., Barat, R., Clarhaut, J. A., Thomas, M., Renoux, B., & Papot, S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.12.045 · Cited by 137
Hirose, T., Sowa, Y., Takahashi, S., Saito, S., Yasuda, C., Shindo, N., Furuichi, K., & Sakai, T. (2003) · Oncogene · doi:10.1038/sj.onc.1207091 · Cited by 137
Solid-Phase Syntheses of β-Turn Analogues To Mimic or Disrupt Protein−Protein Interactions
Burgess, K. (2001) · Accounts of Chemical Research · doi:10.1021/ar9901523 · Cited by 136
Histone deacetylase inhibitors: insights into mechanisms of lethality
Rosato, R. R., & Grant, S. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.809 · Cited by 136
Structure of the LpxC deacetylase with a bound substrate-analog inhibitor
Coggins, B. E., Li, X., McClerren, A. L., Hindsgaul, O., Raetz, C. R. H., & Zhou, P. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb948 · Cited by 135
A Proton-Shuttle Reaction Mechanism for Histone Deacetylase 8 and the Catalytic Role of Metal Ions
Wu, R., Wang, S., Zhou, N., Cao, Z., & Zhang, Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103932d · Cited by 134
Hou, M., Wang, X., Popov, N., Zhang, A., Zhao, X., Zhou, R., Zetterberg, A., Björkholm, M., Arsenian‐Henriksson, M., Gruber, A., et al. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5462 · Cited by 134
Chadha, N., Bahia, M. S., Kaur, M., & Silakari, O. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.03.071 · Cited by 134
Isolation and Characterization of a Novel Class II Histone Deacetylase, HDAC10
Fischer, D. D., Cai, R., Bhatia, U., Asselbergs, F. A. M., Song, C., Terry, R., Trogani, N., Widmer, R., Atadja, P., & Cohen, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108055200 · Cited by 133
The Design of Inhibitors for Medicinally Relevant Metalloproteins
Jacobsen, F. E., Lewis, J. A., & Cohen, S. M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600204 · Cited by 132
The Search for Potent, Small‐Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
Zagni, C., Floresta, G., Monciino, G., & Rescifina, A. (2017) · Medicinal Research Reviews · doi:10.1002/med.21437 · Cited by 132
Chen, Y., Lopez-Sanchez, M., Savoy, D. N., Billadeau, D. D., Dow, G. S., & Kozikowski, A. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701606b · Cited by 132
Regulation of human SRY subcellular distribution by its acetylation/deacetylation
Thevenet, L., Méjean, C., Moniot, B., Bonneaud, N., Galéotti, N., Aldrian, G., Poulat, F., Berta, P., Benkirane, M., & Boizet‐Bonhoure, B. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600352 · Cited by 132
Possible additional antidepressant-like mechanism of sodium butyrate: Targeting the hippocampus
Han, A., Sung, Y.-B., Chung, S.-Y., & Kwon, M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.017 · Cited by 130
Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents
Cappellacci, L., Perinelli, D. R., Maggi, F., Grifantini, M., & Petrelli, R. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867325666181016163110 · Cited by 130
Bubna, A. (2015) · Indian Journal of Dermatology · doi:10.4103/0019-5154.160511 · Cited by 130
Reduced Body Size and Decreased Intestinal Tumor Rates in HDAC2-Mutant Mice
Zimmermann, S., Kiefer, F., Prudenziati, M., Spiller, C., Hansen, J., Floss, T., Wurst, W., Minucci, S., & Göttlicher, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0312 · Cited by 128
Growing the growth cone: remodeling the cytoskeleton to promote axon regeneration
Hur, E., Saijilafu, & Zhou, F. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.002 · Cited by 128
Wen, Q., Gu, Y., Tang, L., Yu, R., & Jiang, J. (2013) · Analytical Chemistry · doi:10.1021/ac403308b · Cited by 128
Structure and autoregulation of the yeast Hst2 homolog of Sir2
Zhao, K., Chai, X., Clements, A. M., & Marmorstein, R. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb978 · Cited by 127
Kuntz, L., Tritsch, D., Grosdemange‐Billiard, C., Hemmerlin, A., Willem, A. L. V. O., Bach, T. J., & Rohmer, M. (2005) · Biochemical Journal · doi:10.1042/bj20041378 · Cited by 127
Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 111Edited by J. Karn
Taplick, J., Kurtev, V., Kroboth, K., Posch, M., Lechner, T., & Seiser, C. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4569 · Cited by 126
Subtype Selective Substrates for Histone Deacetylases
Heltweg, B., Dequiedt, F., Marshall, B. L., Brauch, C., Yoshida, M., Nishino, N., Verdin, E., & Jung, M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0497592 · Cited by 126
Zhao, Y., Sun, H., Lu, J., Li, X., Chen, X., Tao, D., Huang, W., & Huang, B. (2005) · Journal of Experimental Biology · doi:10.1242/jeb.01439 · Cited by 125
Zhao, K., Chai, X., & Marmorstein, R. (2003) · Structure · doi:10.1016/j.str.2003.09.016 · Cited by 125
Metadata
- Authors
- Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Columbia University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Pavletich, Nikola P.
- Venue
- Nature
- Published
- 1999-09
- Volume
- 401
- Issue
- 6749
- Pages
- 188-193
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2135830745
- Cited by
- 1,714
- References
- 28
- Citations by year
- 2026: 39 · 2025: 48 · 2024: 40 · 2023: 55 · 2022: 28 · 2021: 66 · 2020: 62 · 2019: 50 · 2018: 52 · 2017: 70 · 2016: 68 · 2015: 74 · 2014: 67 · 2013: 78 · 2012: 82
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Genentech
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- histone deacetylase, histone deacetylase inhibitors, trichostatin A, vorinostat, Aquifex aeolicus, crystal structure, catalytic site, zinc binding site, hyperthermophilic bacteria, anticancer agents, promyelocytic leukemia
- MeSH terms
- Vorinostat, Amino Acid Sequence, Enzyme Inhibitors, Escherichia coli, Histone Deacetylases, Humans, Hydroxamic Acids, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Recombinant Fusion Proteins, Zinc, Gram-Negative Aerobic Rods and Cocci, Sequence Homology, Amino Acid, Crystallography, X-Ray, Catalytic Domain, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.